2 FTSE 100 dividend stocks for beginners

If you don’t know where to start, these dividend stocks can help you build your portfolio from scratch.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Constructing a dividend portfolio from scratch can seem like a daunting prospect to begin with, but it doesn’t have to be. There are plenty of high-quality blue-chip dividend stocks out there, which would make great income investments for the investing beginner.

GlaxoSmithKline (LSE: GSK) is just one such example. Glaxo is a boring company. Over the past five years, shares in the group have risen by 8%, so if you’re looking for the next Apple or Amazon, you should look elsewhere. 

However, when it comes to income, Glaxo is an income champion. The business of selling pharmaceutical products is a highly defensive one, and Glaxo’s defensive nature means that the company’s dividend yield is one of the most secure in the FTSE 100. Granted, over the past five years the company has struggled to grow as some key products have come off patent. But during the previous two years, growth has returned.

From a low of 76p in 2015, earnings per share are expected to hit 111p for the year ending 31 December 2017, up 46% in two years. Some of this growth has been a direct result of weak sterling, but the firm has also managed to clock up some organic growth as new products have hit the market and sales of existing products have continued to gain traction.

Well diversified 

The great thing about Glaxo is its product diversification. The company manufactures and sells many different pharmaceutical products, meaning that revenue is diversified and falling sales for one product will not undermine overall group sales. This is why Glaxo’s dividend looks to be one of the safest in the FTSE 100. 

City analysts are expecting the company to pay 80p per share in dividends this year, unchanged for the past three years. The payout is expected to be covered 1.4 times by earnings per share, and if the company hits City growth estimates, there’s a chance the payout could rise to 80.3p next year for a yield of 5.1% at current prices. Shares in Glaxo currently trade at a relatively attractive forward P/E of 14.1.

Highly defensive company 

United Utilities (LSE: UU) is another top dividend play for beginners. Water is the world’s most valuable resource, and as one of the largest water groups in the UK, Untied is unlikely to see a fall in demand for its services anytime soon. 

Unfortunately, United’s highly defensive nature means that investors are willing to pay a premium to get their hands on shares in the company. At the time of writing, the shares trade at a forward P/E of 21.7. Still, despite this relatively high valuation, the shares support an attractive dividend yield of 4%, which is slightly above the FTSE 100 average of 3.7%. Put simply, if you’re looking for a slow and steady, predictable income stream, you can’t go wrong with United.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »